FDA advisory committee recommends approval of Pfizer vaccine in the US
An advisory committee of the US Food and Drug Administration (FDA) recommended this Thursday that Pfizer’s vaccine against COVID-19 be approved urgently, in what is a key step for its distribution millions of Americans.
The members of the so-called FDA Vaccine and Biological Products Advisory Committee voted 17 in favor, 4 against and 1 abstention for the vaccine to be administered to all those individuals at least 16 years old, the age from which Pfizer has proven that its safe application.
A vote in favor of the committee is not binding and does not mean that the vaccine was automatically given the green light, as it is up to the FDA to make the final decision.
In an interview today with the NBC network, the commissioner of the FDA, Stephen Hahn, reaffirmed that the approval of the vaccine will arrive “very soon” after the evaluation of the expert committee, although he did not specify the exact date. After the vote, CNN said that approval could come this Friday.